Dr. Marzia Bedoni and Dr. Silvia Picciolini are Guest Editors of a Special Issue entitled "Optical Biosensors for the Detection of Biomarkers" of the open access journal "Sensors".
The aim of this Special Issue is to present the current evolution of optical biosensors for the sensitive and specific detection of new, or already...
Read more
About: Labion
Recent Posts by Labion
LITTLE LABIONS GROW UP
On 9th March 2021, Arianna Iannone has discussed her Master's thesis in Industrial Biotechnology at Università degli Studi di Milano-Bicocca about "BIOCHEMICAL CHARACTERIZATION OF EXTRACELLULAR VESICLES USING SURFACE PLASMON RESONANCE IMAGING: A POTENTIAL TOOL TO DISCOVER PREDICTIVE BIOMARKERS FOR STROKE".
With a final mark of 110/110 cum laude, Arianna has presented the main results of her experimental thesis...
Read more
#NEVERMIND newsletter: women in science and COVID-19
This month the #NEVERMIND newsletter celebrates the women of the Consortium, their great effort in research and the passion for their job!
Moreover, we are pleased to inform you about the recent excellent results from Fondazione Don Gnocchi and the new biophotonic tool to diagnose COVID-19.
Read more
International Day for WOMEN AND GIRLS IN SCIENCE
Today, 11th February, Labion celebrates the International Day for women and girls in Science!
This event was established on 22nd December 2015 and it is intended to "promote full and equal access to and participation in science for women and girls." The International Day of Women and Girls in Science is implemented by UNESCO and
Read more
Newsletter #NEVERMIND is back
2020 has been marked by the COVID-19 pandemic. The NEVERMIND Consortium proved its passion for the project that never stopped! Now we are now ready to face 2021 with renovated energy.
This month we would like to explore the use of nanovectors as vehicles for the mRNA of SARS-CoV-2 and describe how they have been use...
Read more
#NEVERMIND: DECEMBER NEWSLETTER ON LINE
THE FIRST YEAR OF THE #NEVERMIND PROJECT IS ABOUT TO FINISH!
2020 has been the first (out of three) year of the #NEVERMIND project.
The global pandemic has slowed our experiments, but - luckly - we never stopped because our patients need the scientific research to keep going and...
Christmas in advance
The first new instrument granted by Italian Ministry of Health has just arrived!!
This is our Christmas gift in advance On Friday 18th December, Labion researchers were trained and run their very first samples through the ELLA assay."Ella's combination of performance and workflow brings your immunoassays to the next level. In just 90 minutes you get highly...
#NEVERMIND: November newsletter ready to read!
The #NEVERMIND project never stops!
Our young researchers are working hard to synthesize and test new and potent nanovectors to stop Alzheimer's disease progression and eradicate brain cancer. A valuable reasearcher knows that he/she cannot reach the goal by him/herself. You need a team! In the Nevermind Consortium we have experts form multiple fields. This time we would like to introduce...Welcome Francesca!
The Labion team has now a new Member, Francesca Rodà!
Francesca arrived one month ago in Fondazione Don Gnocchi, after obtaining her Master's degree in pharmaceutical chemistry and technologies (CTF) at the University of Turin in July 2020. During her experimental thesis at Advanced Pharmaceutical Nanotechnologies Laboratory (DSTF-UniTO) she has worked on the evaluation of the effect of...#NEVERMIND newsletter first release
Labion team members are happy to announce the release of the first newsletter of the NEVERMIND project!
Our FRRB granted project is the result of the tight collaboration of Fondazione Don Gnocchi with brilliant and outstanding Partners: Università degli studi di Milano-Bicocca, Università degli studi di Milano, Ospedale San Raffaele and Istituto Clinico Humanitas. One of the...Recent Comments by Labion
No comments by Labion yet.
LABION
Who we are.
Labion is a newly established but already International recognized, research laboratory focused on the
application of advanced optical techniques and nanomaterials in medicine.
ACHIEVEMENTS
What we have done.
Several scientific articles, international patents and granted project s are the result of innovation and networking actions.
EXPERTISE
What we can do.
We develop new nanotechnologies and new biophotonics methods by using a multidisciplinary approach at the level of molecules, cells and tissues.